Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome TAP block plus IV PCA after cesarean section
ChiCTR2300077433Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine and butorphanol in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: 72-hour postoperative analgesic effect score, Serum motilin level and 2 more. Started Nov 2023; status: recruiting.
02
Drugs
bupivacainebutorphanol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300077433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077433.